{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/FENC/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T04:44:45.272Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2514,"canonical_name":"FENNEC PHARMACEUTICALS INC.","cik":"0001211583","uei":null,"lei":null,"duns":null,"ticker":"FENC"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":43},"count":43,"timeline":[{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-07-02","url_slug":"/sec/cik-0001211583/4/0001468316-26-000017","accession_number":"0001468316-26-000017","importance":30},{"ts":"2026-07-01","kind":"sec.form144","reporter":"ROSTISLAV RAYKOV","title":"Director","shares":9599,"usd_value":99987,"security_title":"Common","approx_sale_date":"2026-07-01","accession_number":"0001950047-26-006713","importance":40.019997404},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Raykov Rosty","title":"","shares":9599,"price_per_share":10.41,"usd_value":99926,"security_title":"Common shares","importance":35.09992559},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — FENNEC PHARMACEUTICALS INC. — 2026-07-01","url_slug":"/sec/cik-0001211583/144/0001950047-26-006713","accession_number":"0001950047-26-006713","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-07-01","url_slug":"/sec/cik-0001211583/4/0001468308-26-000024","accession_number":"0001468308-26-000024","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-07-01","url_slug":"/sec/cik-0001211583/4/0001926254-26-000010","accession_number":"0001926254-26-000010","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-07-01","url_slug":"/sec/cik-0001211583/4/0002043317-26-000008","accession_number":"0002043317-26-000008","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-07-01","url_slug":"/sec/cik-0001211583/4/0002043395-26-000008","accession_number":"0002043395-26-000008","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-07-01","url_slug":"/sec/cik-0001211583/4/0002043411-26-000010","accession_number":"0002043411-26-000010","importance":30},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Raykov Rosty","title":"","shares":15597,"price_per_share":2.45,"usd_value":38213,"security_title":"Common shares","importance":15.03821265},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"Raykov Rosty","title":"","shares":2778,"price_per_share":0,"usd_value":0,"security_title":"Common shares","importance":15},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Andrade Robert","title":"CHIEF FINANCIAL OFFICER","shares":1703,"price_per_share":0,"usd_value":0,"security_title":"Common shares","importance":15},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Evans Terry L","title":"Chief Commercial Officer","shares":168,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Hackman Jeffrey S.","title":"Chief Executive Officer","shares":1159,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Sayad Pierre Sargis","title":"Chief Medical Officer","shares":168,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Cioffi Christiana Marie","title":"Chief Strategy Officer","shares":156,"price_per_share":0,"usd_value":0,"security_title":"Common shares","importance":15},{"ts":"2026-06-11","kind":"sec.filing","form_type":"S-8","title":"S-8 — FENNEC PHARMACEUTICALS INC. — 2026-06-11","url_slug":"/sec/cik-0001211583/s-8/0001104659-26-073007","accession_number":"0001104659-26-073007","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"8-K","title":"8-K — FENNEC PHARMACEUTICALS INC. — 2026-06-10","url_slug":"/sec/cik-0001211583/8-k/0001104659-26-072425","accession_number":"0001104659-26-072425","importance":35},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-06-10","url_slug":"/sec/cik-0001211583/4/0001589776-26-000002","accession_number":"0001589776-26-000002","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-06-10","url_slug":"/sec/cik-0001211583/4/0001701858-26-000002","accession_number":"0001701858-26-000002","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-06-10","url_slug":"/sec/cik-0001211583/4/0001791004-26-000002","accession_number":"0001791004-26-000002","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-06-02","url_slug":"/sec/cik-0001211583/4/0001468316-26-000015","accession_number":"0001468316-26-000015","importance":30},{"ts":"2026-06-01","kind":"sec.form144","reporter":"ROSTISLAV RAYKOV","title":"Director","shares":9747,"usd_value":93814,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001950047-26-005361","importance":40.01876278},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Raykov Rosty","title":"","shares":9747,"price_per_share":9.62,"usd_value":93766,"security_title":"Common shares","importance":35.09376614},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — FENNEC PHARMACEUTICALS INC. — 2026-06-01","url_slug":"/sec/cik-0001211583/144/0001950047-26-005361","accession_number":"0001950047-26-005361","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-06-01","url_slug":"/sec/cik-0001211583/4/0001468308-26-000022","accession_number":"0001468308-26-000022","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-06-01","url_slug":"/sec/cik-0001211583/4/0001926254-26-000008","accession_number":"0001926254-26-000008","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-06-01","url_slug":"/sec/cik-0001211583/4/0002043317-26-000006","accession_number":"0002043317-26-000006","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-06-01","url_slug":"/sec/cik-0001211583/4/0002043395-26-000006","accession_number":"0002043395-26-000006","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — FENNEC PHARMACEUTICALS INC. — 2026-06-01","url_slug":"/sec/cik-0001211583/4/0002043411-26-000008","accession_number":"0002043411-26-000008","importance":30},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Raykov Rosty","title":"","shares":15597,"price_per_share":2.45,"usd_value":38213,"security_title":"Common shares","importance":15.03821265},{"ts":"2026-05-31","kind":"sec.insider.a","reporter":"Andrade Robert","title":"CHIEF FINANCIAL OFFICER","shares":1703,"price_per_share":0,"usd_value":0,"security_title":"Common shares","importance":15},{"ts":"2026-05-31","kind":"sec.insider.a","reporter":"Hackman Jeffrey S.","title":"Chief Executive Officer","shares":1159,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-05-31","kind":"sec.insider.a","reporter":"Evans Terry L","title":"Chief Commercial Officer","shares":168,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-05-31","kind":"sec.insider.a","reporter":"Sayad Pierre Sargis","title":"Chief Medical Officer","shares":168,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-05-31","kind":"sec.insider.a","reporter":"Cioffi Christiana Marie","title":"Chief Strategy Officer","shares":156,"price_per_share":0,"usd_value":0,"security_title":"Common shares","importance":15},{"ts":"2026-05-31","kind":"sec.insider.a","reporter":"Raykov Rosty","title":"","shares":2778,"price_per_share":0,"usd_value":0,"security_title":"Common shares","importance":15},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — FENNEC PHARMACEUTICALS INC. — 2026-05-18","url_slug":"/sec/cik-0001211583/8-k/0001104659-26-063271","accession_number":"0001104659-26-063271","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — FENNEC PHARMACEUTICALS INC. — 2026-05-15","url_slug":"/sec/cik-0001211583/schedule-13g-a/0001604867-26-000010","accession_number":"0001604867-26-000010","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — FENNEC PHARMACEUTICALS INC. — 2026-05-14","url_slug":"/sec/cik-0001211583/10-q/0001104659-26-061213","accession_number":"0001104659-26-061213","importance":45},{"ts":"2026-05-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — FENNEC PHARMACEUTICALS INC. — 2026-05-14","url_slug":"/sec/cik-0001211583/schedule-13g-a/0001622627-26-000014","accession_number":"0001622627-26-000014","importance":30},{"ts":"2026-05-11","kind":"sec.insider.s","reporter":"RALLIS CHRIS A","title":"","shares":8346,"price_per_share":7.04,"usd_value":58756,"security_title":"Common Shares","importance":35.05875584},{"ts":"2026-05-11","kind":"sec.insider.m","reporter":"RALLIS CHRIS A","title":"","shares":14344,"price_per_share":2.44,"usd_value":34999,"security_title":"Common Shares","importance":15.03499936}]}